fluconazole has been researched along with quercetin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Jin, YS | 1 |
| Agafonova, NA; Borisevich, SS; Burgart, YV; Chupakhin, ON; Evstigneeva, NP; Gerasimova, NA; Krasnykh, OP; Kungurov, NV; Kushch, SO; Makhaeva, GF; Maslova, VV; Rudakova, EV; Saloutin, VI; Shchegolkov, EV; Solodnikov, SY; Triandafilova, GA; Ulitko, MV; Zilberberg, NV | 1 |
| Cavalcanti, BC; da Silva, CR; de Andrade Neto, JB; de Andrade, GM; de Barros Viana, GS; de Moraes, MO; de Sousa Campos, R; Figueiredo, NS; Gaspar, DM; Grangeiro, TB; Lima, IS; Lobo, MD; Magalhães, HI; Nobre Júnior, HV; Sampaio, LS | 1 |
| Hu, H; Lou, Y; Qiu, Y; Wang, L; Zeng, S; Zhang, X; Zheng, J | 1 |
| Naqvi, AH; Pandey, G; Rawat, AK; Roy, S; Singh, BN; Singh, BR; Upreti, DK; Verma, S | 1 |
| Gao, M; Wang, H; Zhu, L | 1 |
| Kim, S; Lee, DG; Woo, ER | 1 |
1 review(s) available for fluconazole and quercetin
| Article | Year |
|---|---|
Recent advances in natural antifungal flavonoids and their derivatives.
Topics: Antifungal Agents; Biological Products; Flavonoids; Fungi; Humans; Mycoses | 2019 |
10 other study(ies) available for fluconazole and quercetin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
Topics: Animals; Bacteria; Drug Screening Assays, Antitumor; Epidermophyton; HeLa Cells; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Nitroso Compounds; Pyrazoles; Rats, Sprague-Dawley; Structure-Activity Relationship; Trichophyton | 2020 |
Synergistic effect of the flavonoid catechin, quercetin, or epigallocatechin gallate with fluconazole induces apoptosis in Candida tropicalis resistant to fluconazole.
Topics: Antifungal Agents; Apoptosis; Candida tropicalis; Catechin; Drug Interactions; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Microbial Sensitivity Tests; Quercetin; Reactive Oxygen Species | 2014 |
Metabolism of chamaechromone in vitro with human liver microsomes and recombinant human drug-metabolizing enzymes.
Topics: Antiviral Agents; Benzoflavones; Cytochrome P-450 CYP1A2; Drug Interactions; Drugs, Chinese Herbal; Flavones; Fluconazole; Glucuronosyltransferase; Humans; Hydroxylation; In Vitro Techniques; Liver; Microsomes, Liver; Naphthols; Plant Roots; Quercetin; Recombinant Proteins; Thymelaeaceae | 2014 |
Quercetin sensitizes fluconazole-resistant candida albicans to induce apoptotic cell death by modulating quorum sensing.
Topics: Antifungal Agents; Antioxidants; Apoptosis; Biofilms; Candida albicans; Drug Resistance, Fungal; Fluconazole; Hyphae; Microbial Sensitivity Tests; Quercetin; Quorum Sensing; Usnea; Virulence Factors | 2015 |
Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
Topics: Animals; Antifungal Agents; Bacterial Adhesion; Biofilms; Candida albicans; Candidiasis, Vulvovaginal; Cell Membrane; Disease Models, Animal; Drug Resistance, Fungal; Drug Synergism; Female; Flocculation; Fluconazole; Gene Expression Regulation, Fungal; Hydrophobic and Hydrophilic Interactions; Hyphae; Mice; Microbial Sensitivity Tests; Microbial Viability; Plankton; Quercetin; RNA, Messenger | 2016 |
Synergistic Antifungal Activity of Isoquercitrin: Apoptosis and Membrane Permeabilization Related to Reactive Oxygen Species in Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Apoptosis; Candida albicans; Caspases; Catalase; Cell Membrane; Cell Membrane Permeability; Drug Combinations; Drug Synergism; Enzyme Activation; Fluconazole; Flucytosine; Free Radical Scavengers; Microbial Sensitivity Tests; Oxidative Stress; Quercetin; Reactive Oxygen Species; Superoxide Dismutase | 2019 |